Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 10, 1994JAMA

The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

PVPaul A. VolberdingBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Paul A. Volberding (1994) studied this question.

synapsesocial.com/papers/6a708f372163a0a01bc4c583https://doi.org/10.1001/jama.1994.03520060037029
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Toxic Effects of Zidovudine in Asymptomatic Human Immunodeficiency Virus-Infected Individuals With CD4 + Cell Counts of 0.50×10 9 /L or Less1992 · 23 citations
  2. 2Comparison of Long-term Prognosis of Patients With AIDS Treated and Not Treated With Zidovudine1994 · 66 citations
  3. 3A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection1992 · 326 citations
  4. 4The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex1987 · 3,000 citations
  5. 5CD4+ Lymphocytes Are an Incomplete Surrogate Marker for Clinical Progression in Persons with Asymptomatic HIV Infection Taking Zidovudine1993 · 190 citations